601.948.8005

Call Now For A Free Consultation

Facebook

Twitter

Se Habla Español

Zantac Cancer

Chhabra & Gibbs, P.A. > Blog  > Zantac Cancer

Recall on Zantac

zantac recall

Our Partner Firm, Chhabra Gibbs & Herrington PLLC, wrote about the recent Zantac recall and how the FDA has decided to pull all of the Zantac product off the shelf due to NDMA and cancer from contamination: The heartburn and ulcer medication Zantac, also known as Ranitidine, which belongs to the histamine-2 blockers category, has been recalled by the FDA.   The FDA has been investigating Zantac for a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications.  The FDA has determined that the impurity increases over time and when stored at higher than room temperatures, that impurity exposes consumers to an unacceptable level of it....

Continue reading

Zantac Cancer Lawsuits

zantac cancer

Zantac, or its generic form Ranitidine, is used to treat and prevent the formation of ulcers in the stomach and counteract the accumulation of acid in the stomach that may lead to gastroesophageal reflux disease (GERD). Recently, the U.S. Food and Drug Administration (FDA) alerted the public that some ranitidine medications, including Zantac, contain low levels of a possible human carcinogen known as N-nitrosodimethylamine (NDMA). The FDA is currently assessing the risk posed to patients from the presence of NDMA. This compound is classified as a potentially dangerous cancer-causing agent, and is used in gasoline, rocket fuel, as a stabilizer in...

Continue reading
Translate »